Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells. [electronic resource]
Producer: 20200810Description: 354-370.e7 p. digitalISSN:- 1878-3686
- Adult
- Aged
- Animals
- Antineoplastic Agents -- administration & dosage
- Brain Neoplasms -- drug therapy
- Carcinoma, Pancreatic Ductal -- drug therapy
- Cell Line
- Dendritic Cells -- drug effects
- Doxorubicin -- administration & dosage
- Drug Delivery Systems -- methods
- ErbB Receptors -- administration & dosage
- Female
- Glioblastoma -- drug therapy
- Humans
- Immunity, Innate -- drug effects
- Immunotherapy -- methods
- Male
- Mice
- Mice, Inbred BALB C
- Nanostructures -- chemistry
- Pancreatic Neoplasms -- drug therapy
- Salmonella typhimurium -- cytology
No physical items for this record
Publication Type: Case Reports; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.